EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:166975 - soybean oil
| ChEBI ID | CHEBI:166975 |
| ChEBI Name | soybean oil |
| Stars | |
| Definition | An oil extracted from the seeds of Glycine max. Typical fatty acid composition is 51% linoleic acid, 7-10% α-linolenic acid, 23% oleic acid, 10% palmitic acid and 4% stearic acid. |
| Last Modified | 7 January 2021 |
| Submitter | chanl |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | fixative Any compound used for the purpose of preserving biological tissues from decay in such a way as to allow for the preparation of thin, stained sections for subsequent histological study. insulin-sensitizing drug An agent which overcomes insulin resistance by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma). anti-obesity agent Any substance which is used to reduce or control weight. |
| Applications: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. gastrointestinal drug A drug used for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion. insulin-sensitizing drug An agent which overcomes insulin resistance by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma). hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antidote to organophosphate poisoning A role borne by a molecule that acts to counteract or neutralise the deleterious effects of organophosphates or acetylcholinesterase inhibitors (nerve agents). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| soybean oil (CHEBI:166975) has part hexadecanoic acid (CHEBI:15756) |
| soybean oil (CHEBI:166975) has part linoleic acid (CHEBI:17351) |
| soybean oil (CHEBI:166975) has part octadecanoic acid (CHEBI:28842) |
| soybean oil (CHEBI:166975) has part oleic acid (CHEBI:16196) |
| soybean oil (CHEBI:166975) has part α-linolenic acid (CHEBI:27432) |
| soybean oil (CHEBI:166975) has role anti-arrhythmia drug (CHEBI:38070) |
| soybean oil (CHEBI:166975) has role anti-obesity agent (CHEBI:74518) |
| soybean oil (CHEBI:166975) has role antidote to organophosphate poisoning (CHEBI:90753) |
| soybean oil (CHEBI:166975) has role antihypertensive agent (CHEBI:35674) |
| soybean oil (CHEBI:166975) has role antineoplastic agent (CHEBI:35610) |
| soybean oil (CHEBI:166975) has role antipsychotic agent (CHEBI:35476) |
| soybean oil (CHEBI:166975) has role fixative (CHEBI:50913) |
| soybean oil (CHEBI:166975) has role gastrointestinal drug (CHEBI:55324) |
| soybean oil (CHEBI:166975) has role hypoglycemic agent (CHEBI:35526) |
| soybean oil (CHEBI:166975) has role insulin-sensitizing drug (CHEBI:50864) |
| soybean oil (CHEBI:166975) is a mixture (CHEBI:60004) |
| Synonyms | Source |
|---|---|
| extract of soy | ChemIDplus |
| Glycine max seed oil | ChEMBL |
| Intralipid (fresenius) | ChEMBL |
| Liposyn (hospira) | ChEMBL |
| Nutrilipid (b braun) | ChEMBL |
| oils, soybean | ChemIDplus |
| Brand Names | Source |
|---|---|
| Intrafat | KEGG DRUG |
| Intralipid | KEGG DRUG |
| Soybean oil component of endolipide soya oil | ChEMBL |
| Soybean oil component of smoflipid | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| D04962 | KEGG DRUG |
| DB09422 | DrugBank |
| Soybean_oil | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:8001-22-7 | ChemIDplus |
| Citations |
|---|